H HIMS & HERS HEALTH INC
| Market Cap | $4.91B |
| P/E Ratio | 42.22 |
| Forward P/E | 14.36 |
| Dividend Yield | — |
| Beta | 2.61 |
| 52W Range | $13.74 - $70.43 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Polen Capital Management Polen Capital Management | 0.00% | $0 | 0 | Sold |
Insider Trading
| Insider Name of the company insider who made the trade 47 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Okupe OluyemiChief Financial Officer | Sale | 9,217 | $23.77 | $219.07K | 20 Mar 2026 | 20 Mar 2026 |
| Boughton SoleilChief Legal Officer | Sale | 4,812 | $24.69 | $118.81K | 17 Mar 2026 | 17 Mar 2026 |
| Chi MichaelChief Operating Officer | Sale | 97,289 | $24.69 | $2.40M | 17 Mar 2026 | 17 Mar 2026 |
| Becklund IrenePAO | Sale | 5,529 | $24.69 | $136.51K | 17 Mar 2026 | 17 Mar 2026 |
| Boughton SoleilChief Legal Officer | Sale | 4,651 | $15.21 | $70.74K | 27 Feb 2026 | 02 Mar 2026 |
| Okupe OluyemiChief Financial Officer | Sale | 5,262 | $26.44 | $139.11K | 03 Feb 2026 | 04 Feb 2026 |
| Oluyemi OkupeChief Financial Officer | Sale | 5,262 | $26.44 | $139.11K | 03 Feb 2026 | 04 Feb 2026 |
| Okupe OluyemiChief Financial Officer | Sale | 9,067 | $30.34 | $275.11K | 20 Jan 2026 | 21 Jan 2026 |
| Okupe OluyemiChief Financial Officer | Sale | 9,070 | $33.79 | $306.45K | 05 Jan 2026 | 07 Jan 2026 |
| Oluyemi OkupeChief Financial Officer | Sale | 9,070 | $33.79 | $306.45K | 05 Jan 2026 | 07 Jan 2026 |
| Okupe OluyemiChief Financial Officer | Sale | 23,090 | $35.72 | $824.71K | 22 Dec 2025 | 23 Dec 2025 |
| Chi MichaelChief Operating Officer | Sale | 13,750 | $36.71 | $504.76K | 17 Dec 2025 | 18 Dec 2025 |
| Autor Deborah M.Chief Policy Officer | Sale | 7,054 | $36.71 | $258.95K | 17 Dec 2025 | 18 Dec 2025 |
| Becklund IrenePAO | Sale | 8,411 | $36.71 | $308.77K | 17 Dec 2025 | 18 Dec 2025 |
| Carroll Patrick HarrisonChief Medical Officer | Sale | 10,021 | $36.71 | $367.87K | 17 Dec 2025 | 18 Dec 2025 |
| Perez Garcia Andrea G | Sale | 2,500 | $39.17 | $97.92K | 09 Dec 2025 | 10 Dec 2025 |
| Boughton SoleilChief Legal Officer | Sale | 2,631 | $35.22 | $92.66K | 24 Nov 2025 | 25 Nov 2025 |
| Soleil BoughtonChief Legal Officer | Sale | 2,631 | $35.22 | $92.66K | 24 Nov 2025 | 25 Nov 2025 |
| Okupe OluyemiChief Financial Officer | Sale | 23,187 | $36.81 | $853.49K | 17 Nov 2025 | 19 Nov 2025 |
| Oluyemi OkupeChief Financial Officer | Sale | 23,187 | $36.81 | $853.49K | 17 Nov 2025 | 19 Nov 2025 |
| Boughton SoleilChief Legal Officer | Sale | 2,637 | $42.53 | $112.15K | 10 Nov 2025 | 12 Nov 2025 |
| Boughton SoleilChief Legal Officer | Sale | 2,637 | $50.10 | $132.11K | 27 Oct 2025 | 28 Oct 2025 |
| Soleil BoughtonChief Legal Officer | Sale | 2,637 | $50.10 | $132.11K | 27 Oct 2025 | 28 Oct 2025 |
| Okupe OluyemiChief Financial Officer | Sale | 11,592 | $57.13 | $662.22K | 17 Oct 2025 | 20 Oct 2025 |
| Oluyemi OkupeChief Financial Officer | Sale | 11,592 | $57.13 | $662.22K | 17 Oct 2025 | 20 Oct 2025 |
| Dudum AndrewChief Executive Officer | Sale | 2,335 | $63.39 | $148.01K | 16 Oct 2025 | 20 Oct 2025 |
| Dudum AndrewChief Executive Officer | Sale | 39,531 | $62.71 | $2.48M | 16 Oct 2025 | 20 Oct 2025 |
| Dudum AndrewChief Executive Officer | Sale | 8,423 | $63.46 | $534.51K | 16 Oct 2025 | 20 Oct 2025 |
| Dudum AndrewChief Executive Officer | Sale | 39,111 | $62.70 | $2.45M | 16 Oct 2025 | 20 Oct 2025 |
| Dudum AndrewChief Executive Officer | Sale | 16,667 | $62.70 | $1.04M | 16 Oct 2025 | 20 Oct 2025 |
| Dudum AndrewChief Executive Officer | Sale | 39,332 | $62.70 | $2.47M | 16 Oct 2025 | 20 Oct 2025 |
| Dudum AndrewChief Executive Officer | Sale | 10,469 | $63.49 | $664.63K | 16 Oct 2025 | 20 Oct 2025 |
| Dudum AndrewChief Executive Officer | Sale | 17,001 | $62.69 | $1.07M | 16 Oct 2025 | 20 Oct 2025 |
| Dudum AndrewChief Executive Officer | Sale | 2,792 | $62.65 | $174.92K | 16 Oct 2025 | 20 Oct 2025 |
| Andrew DudumChief Executive Officer | Sale | 39,332 | $62.70 | $2.47M | 16 Oct 2025 | 20 Oct 2025 |
| Andrew DudumChief Executive Officer | Sale | 10,469 | $63.49 | $664.63K | 16 Oct 2025 | 20 Oct 2025 |
| Andrew DudumChief Executive Officer | Sale | 39,531 | $62.71 | $2.48M | 16 Oct 2025 | 20 Oct 2025 |
| Andrew DudumChief Executive Officer | Sale | 17,001 | $62.69 | $1.07M | 16 Oct 2025 | 20 Oct 2025 |
| Andrew DudumChief Executive Officer | Sale | 8,423 | $63.46 | $534.51K | 16 Oct 2025 | 20 Oct 2025 |
| Andrew DudumChief Executive Officer | Sale | 39,111 | $62.70 | $2.45M | 16 Oct 2025 | 20 Oct 2025 |
| Andrew DudumChief Executive Officer | Sale | 16,667 | $62.70 | $1.04M | 16 Oct 2025 | 20 Oct 2025 |
| Andrew DudumChief Executive Officer | Sale | 2,335 | $63.39 | $148.01K | 16 Oct 2025 | 20 Oct 2025 |
| Andrew DudumChief Executive Officer | Sale | 2,792 | $62.65 | $174.92K | 16 Oct 2025 | 20 Oct 2025 |
| Boughton SoleilChief Legal Officer | Sale | 2,637 | $54.38 | $143.40K | 13 Oct 2025 | 14 Oct 2025 |
| Soleil BoughtonChief Legal Officer | Sale | 2,637 | $54.38 | $143.40K | 13 Oct 2025 | 14 Oct 2025 |
| Chi MichaelChief Commercial Officer | Sale | 900 | $58.25 | $52.42K | 10 Oct 2025 | 14 Oct 2025 |
| Michael ChiChief Commercial Officer | Sale | 900 | $58.25 | $52.42K | 10 Oct 2025 | 14 Oct 2025 |
Frequently Asked Questions
What is HIMS stock price today?
HIMS & HERS HEALTH INC (HIMS) is currently trading at $21.53. The stock has a 52-week range of $13.74 to $70.43 and a market capitalization of $4.91B.
Is HIMS a good stock to buy in 2026?
HIMS & HERS HEALTH INC has a P/E ratio of 42.2 (forward P/E: 14.4), a dividend yield of none, and 1-year performance of -35.6%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling HIMS stock?
There have been 47 insider transactions for HIMS in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has HIMS stock performed over the past year?
HIMS & HERS HEALTH INC (HIMS) has returned -35.6% over the past 12 months. The stock traded between $13.74 and $70.43 during this period, and is currently at $21.53.
Which hedge funds own HIMS (HIMS & HERS HEALTH INC)?
1 tracked hedge funds currently hold HIMS in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is HIMS's market cap and valuation?
HIMS & HERS HEALTH INC (HIMS) has a market capitalization of $4.91B. The trailing P/E ratio is 42.2 and forward P/E is 14.4. The stock is classified in the Healthcare sector.
What is HIMS's revenue and profitability?
HIMS & HERS HEALTH INC reported revenue of $2.35B with net income of $128.37M and a profit margin of 0.05%. The stock has a beta of 2.61.
What sector is HIMS in and who are its biggest institutional holders?
HIMS & HERS HEALTH INC (HIMS) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.